HYDROXYCHLOROQUINE IN THE TREATMENT OF SJOGREN SYNDROME

被引:0
|
作者
WYNGAARDEN, JB [1 ]
机构
[1] NIH, BETHESDA, MD 20205 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:649 / 649
页数:1
相关论文
共 50 条
  • [1] Remission of Secondary Membranous Nephropathy From Sjogren Syndrome After Treatment With Hydroxychloroquine
    Al-Tuhafy, Dina R.
    Ancion, Jean H.
    Sajid, Saira
    Hysi, Katerina
    Drakakis, James
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 505 - 505
  • [2] Safety and Efficacy of Oral Hydroxychloroquine in the Treatment of Ophthalmic Disease Associated with Sjogren's Syndrome
    Wang Fang
    Zhou Qingqing
    Luo Qihui
    Zhong Bing
    Huang Xinyue
    Xiong Jie
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2023, 29 (08) : 656 - 662
  • [3] Treatment of primary Sjogren's syndrome with hydroxychloroquine: A retrospective, open-label study
    Fox, RI
    Dixon, R
    Guarrasi, V
    Krubel, S
    LUPUS, 1996, 5 : S31 - S36
  • [4] Lack of Efficacy of Early Treatment with Hydroxychloroquine in a Group of Hispanics with Primary Sjogren's Syndrome
    Gonzalez-Melendez, Ariana
    Jordan-Gonzalez, Patricia
    Gago-Pinero, Ricardo
    Varela-Rosario, Noemi
    Perez-Rios, Naydi
    Vila, Luis
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] Effect of Hydroxychloroquine on the Lipid Profile of Patients with Sjogren Syndrome
    Migkos, Michail P.
    Markatseli, Theodora E.
    Iliou, Chrisoula
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (05) : 902 - 908
  • [6] Cardiovascular Protection of Hydroxychloroquine in Patients with Sjogren's Syndrome
    Yang, Deng-Ho
    Wang, Yu-Hsun
    Pan, Lung-Fa
    Wei, James Cheng-Chung
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 10
  • [7] The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjogren's Syndrome: A Systematic Review and Meta-Analysis
    Wang, Xuan
    Zhang, Tongyangzi
    Guo, Zizhen
    Pu, Jincheng
    Riaz, Farooq
    Feng, Run
    Fang, Xingxing
    Song, Jiamin
    Liang, Yuanyuan
    Wu, Zhenzhen
    Pan, Shengnan
    Tang, Jianping
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Hydroxychloroquine treatment for primary Sjogren's syndrome: its effect on salivary and serum inflammatory markers
    Tishler, M
    Yaron, I
    Shirazi, I
    Yaron, M
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (04) : 253 - 256
  • [9] Primary Sjogren's Syndrome: Extraglandular Manifestations and Hydroxychloroquine Therapy
    Demarchi, Julia
    Beatriz Papasidero, Silvia
    Medina, Maria Alejandra
    Klajn, Diana
    Chaparro del Mora, Rafael
    Luis Rillo, Oscar
    Victoria Martire, Maria
    Crespo, Gloria
    Secco, Anastasia
    Catalan Pellet, Antonio
    Amitrano, Cristina
    Crow, Catherine
    Asnal, Cecilia
    Pucci, Paula
    Caeiro, Francisco
    Benzaquen, Nadia
    Pablo Pirola, Juan
    Colazo, Marcela
    Mayer, M.
    Zazzetti, F.
    Velez, S.
    Barreira, J. C.
    Tamborenea, Natalia
    Santiago, M. L.
    Raiti, Laura
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] Primary Sjogren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy
    Demarchi, J.
    Papasidero, S.
    Medina, M. A.
    Klajn, D.
    Chaparro del Moral, R.
    Rillo, O.
    Martire, V.
    Crespo, G.
    Secco, A.
    Catalan Pellet, A.
    Amitrano, C.
    Crow, C.
    Asnal, C.
    Pucci, P.
    Caeiro, F.
    Benzanquen, N.
    Pirola, J. P.
    Mayer, M.
    Zazzetti, F.
    Velez, S.
    Barreira, J.
    Tamborenea, N.
    Santiago, L.
    Raiti, L.
    CLINICAL RHEUMATOLOGY, 2017, 36 (11) : 2455 - 2460